Thomas R. Staab, II
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thomas R. Staab, II
Thomas R. Staab, II is recorded as CFO at Tenax Therapeutics, Inc. (TENX). Tenax Therapeutics, Inc. reported in an 8-K filed April 22, 2026 that Thomas R. Staab, II was appointed Chief Financial Officer, effective May 11, 2026.
“On April 22, 2026, Tenax Therapeutics, Inc. (the “Company”) announced the appointment of Thomas R. Staab, II as Chief Financial Officer of the Company effective May 11, 2026 (the “Start Date”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-11–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tenax Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher T. Giordano CEO, Board Member
- Christopher Thomas Giordano CEO, Board Member
- Gerald Proehl Chairman
- Eliot M. Lurier CFO
- Lawrence R. Hoffman CFO, Chief Accounting Officer
- Thomas A. McGauley CFO, Chief Accounting Officer
- Declan Doogan Board Member
- Gerald T. Proehl Board Member
- June Almenoff Board Member
- Keith Maher Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.